The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Respiratory failure from ventilatory depression (due to neuromuscular blockade/paralysis)
Publications
The Use of Benzodiazepine Receptor Agonists and Risk of Respiratory Failure in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Case-Control Study.
Sleep. 2015;38(7):1045-50
Respiratory acidosis secondary to drug therapy.
Archivos de bronconeumologia. 2015;51(4):204-5
Comparison of toxicity associated with nonmedical use of benzodiazepines with buprenorphine or methadone.
Drug and alcohol dependence. 2014;138:118-23
Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphine.
Journal of analytical toxicology. 2013;37(9):636-41
Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases.
Journal of analytical toxicology. 2003;27(7):499-504
Mechanism of respiratory insufficiency in pure or mixed drug-induced coma involving benzodiazepines.
Journal of toxicology. Clinical toxicology. 2002;40(1):35-47